Understanding potential risks helps users make informed decisions about their peptide therapy and manage any unexpected reactions effectively
CJC and ipamorelin are dosed daily in micrograms
However, neurotrophins have had little success in clinical trials directed at neurodegenerative diseases due to their poor pharmokinetic profile and large molecular weight that significantly impedes penetration of the BBB [61,62]
In immunopeptidomics we need a sniper instead of a shotgun
If the solution remains cloudy or contains visible particulates after 15 minutes, the peptide may have degraded during shipping or storage
Limagne E, Nuttin L, Thibaudin M, Jacquin E, Aucagne R, Bon M, et al